Özet:

The most commonly used strategies in the treatment of hypoxemine in patients diagnosed with coronavirus disease 2019 (COVID-19) in the Intensive Care Unit (ICU) are high-flow nasal oxygenization (HFNO) and non-invasive ventilation (NIV) strategies. In this prospective study, we aimed at comparing the effects of these two therapeutic methods used conversively in the same patient. Method and method: Acute hypoxemic respiratory failure (AHSY) and COVID-19-related acute respiratory distress syndrome (ARDS) have been diagnosed with 1 hour standard oxygen therapy for patients in the YBU. HFNO and NIV were transitionally applied to patients who meet the inclusion criteria and the effects of HFNO and NIV were studied on the same patient. Results: COVID-19 ARDS meets the inclusion criteria of thirty of the fourteen patients accepted to the UNHCR. According to the blood gas values of the first and second arteries, the rate of PaO2/FiO2 (P/F) during the NIV was significantly higher compared to both the initial and the HFNO. In addition, the ROX index was significantly higher than HFNO during HIV, and the SpO2 value in HIV increased significantly compared to the initial value. In both methods, the patient’s satisfaction was better according to the visual analog scale than the standard oxygen therapy (SOT). Six percent of patients (24/30) were orotrakeal entubated; 13 patients were sent to the service (43.3 percent), 2 patients were deported (6.7 percent), 15 patients died (50 percent). The result: in COVID-19 and other causes related AHSY and ARDS patients, starting with HFNO and/or NIV to respiratory support instead of SOT is more effective in healing oxygenization. HFNO is more effective in increasing NIV, SpO2 and (PaO2/FiO2) P/F.

Anahtar Kelimeler: